Sunday , April 22 2018
Home / health & Fitness / Quarter of children in north Wales overweight or obese

Quarter of children in north Wales overweight or obese

Media playback is unsupported on your device

Media captionParents tried to get their children to stay away from junk food.

Action is needed to cut the number of north Wales children who are overweight or obese when they start primary school, a report has warned.

More than a quarter of four and five year olds in the region are in the category.

Betsi Cadwaladr health board has drawn up a three-year plan, including helping pregnant women to manage their weight.

But a health expert said being overweight was becoming a "social norm".

Just over 28.6% of four and five year olds in the region are overweight, including 12% who are obese, according to a report to be considered by the board on Thursday.

The report, "Children's health and wellbeing: The impact across the life course", said this was a problem which continued into adulthood in a "vast majority" of cases.

It warned: "Obesity in childhood leads to significant health issues across the life course, and some areas of north Wales have the highest prevalence of childhood obesity in the UK."

The report also found "considerable gaps in north Wales in obesity services to support children and families".

Across Wales, the Child Measurement Programme, published in August 2016, found 26% of reception-aged children were classed as overweight or obese.

Sioned Quirke, an obesity specialist and spokeswoman for British Dietetic Association Wales, said: "Published figures every year are showing an increase [in overall obesity].

"We are not even at the stage where they are levelling out.

"That's not surprising taking into account the type of patients we are seeing every day and the numbers being referred to us. The numbers are increasing every year."

Media playback is unsupported on your device

Media captionIn 2017, Prof Nadim Haboubi said action was needed to stop children being affected by an obesity "explosion" in Wales

She warned the amount people are overweight by is also "getting worse".

"It's something that's becoming quite apparent, it's becoming the social norm," Ms Quirke added.

"People will compare themselves to other people and if others are obese or bigger than them, we think we are ok.

"People constantly say 'I'm not that big' but they are comparing themselves to people who are bigger."

The health board's draft three-year plan includes improving breastfeeding rates, infant feeding in general and healthy weaning, as well as reducing obesity levels in mothers.

It also focuses on promoting the new national guidance on childhood obesity which includes which includes ensuring children play outside every day, limiting screen time, daily fruit and vegetable intake and having enough sleep.

The report has recommended the board continues to use "evidence-based actions" which have been set out in the plan.

About admin

Our goal is to help you improve your life and improve your standard of living and gain more knowledge about what to do in all cases whether Business and Investing or Arts and Entertainment or

Check Also

Cystic fibrosis: Company urged to lower cost of life-changing drug

Image caption More than 10,000 people in the UK suffer from cystic fibrosis, which causes fatal lung damageA pharmaceutical company has been urged to drop the price of a life-changing cystic fibrosis drug for the NHS. Orkambi, which is made by Vertex Pharmaceuticals, is not available on the NHS and health ministers have called for an "urgent resolution". NHS England made a counter-offer to the initial deal but Vertex said that would not allow them to fund future medicines. Vertex said it wanted to reach an agreement "as soon as possible". Cystic fibrosis is a life-shortening genetic condition that causes fatal lung damage and affects around 10,400 people in the UK. Only around half of those with cystic fibrosis live to celebrate their 40th birthday. Orkambi is for people with the F508del mutation, which causes the production of an abnormal protein that disrupts how water and chloride are transported in the body. The drug has been shown in clinical trials to improve lung function..

Leave a Reply

Your email address will not be published. Required fields are marked *